Mary Hoang, MD
Family Medicine · New Orleans, LANPI 1083913479
Payments from drug & device makers
Across 305 payments — averaging $18.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$769
- Novo Nordisk$504
- Pfizer$472
- Viiv Healthcare Company$449
- Astellas Pharma US Inc$431
- AstraZeneca$333
- plus $3K from 33 others
What the payments were for
- Food & beverage$5,541100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $769 |
| Novo Nordisk | 39 | $504 |
| Pfizer | 28 | $472 |
| Viiv Healthcare Company | 16 | $449 |
| Astellas Pharma US Inc | 19 | $431 |
| AstraZeneca | 23 | $333 |
| Gilead | 6 | $333 |
| Johnson & Johnson | 14 | $297 |
| GSK | 22 | $281 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $249 |
| Lilly USA, LLC | 14 | $194 |
| Boehringer Ingelheim | 7 | $105 |
| Tris Pharma Inc | 5 | $99 |
| Amgen | 6 | $85 |
| Daiichi Sankyo Inc. | 4 | $80 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $73 |
| Ironshore Pharmaceuticals Inc. | 4 | $70 |
| Supernus Pharmaceuticals, Inc. | 3 | $68 |
| Merck | 3 | $58 |
| Bayer | 4 | $55 |
| Sunovion Pharmaceuticals Inc. | 3 | $52 |
| Novartis | 3 | $50 |
| Abbott | 3 | $48 |
| E.r. Squibb & Sons, L.L.C. | 3 | $41 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $36 |
| Shire North American Group Inc | 2 | $36 |
| Antares Pharma, Inc. | 2 | $30 |
| Acerus Pharmaceuticals Corporation | 2 | $30 |
| Exact Sciences | 2 | $30 |
| Almatica Pharma LLC | 1 | $27 |
| Ironwood Pharmaceuticals, Inc | 2 | $26 |
| Eisai Inc. | 2 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Philips North America LLC | 1 | $18 |
| Genentech USA, Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $12 |
| Sanofi Pasteur Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,541 in reported general payments places this provider in the 80th percentile of 1,469 family medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Montelukast Sodium | 23 | $426 |
| Isosorbide Dinitrate | 13 | $413 |
| Nifedipine ErNifedipine | 13 | $374 |
| Rosuvastatin Calcium | 19 | $336 |
| Losartan Potassium | 17 | $245 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $245 |
| Potassium Chloride | 13 | $226 |
| Atorvastatin Calcium | 23 | $202 |
| Furosemide | 20 | $131 |
| Metoprolol Succinate | 11 | $100 |
| Hydrochlorothiazide | 12 | $25 |
Paid to pharmacies, not to this prescriber.
Other family medicine in New Orleans
- Stephen JonesNew Orleans$513K
- Kristen ThomasNew Orleans$361K
- Ibrahim ZeinatyNew Orleans$13K
- Clinton GuilloryMonroe$18.5M
- Jason MorrisLake Charles$18M
- Michael SeepLake Charles$9.1M
- William NaboursLake Charles$3M
- Ramon VargasKenner$2.1M
- Joshua WhatleyLake Charles$366K
- Richard JeansonneMandeville$362K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.